 MASON, Ohio--BUSINESS WIRE--AtriCure, Inc. Nasdaq: ATRC, a leading innovator in surgical treatments for atrial fibrillation Afib and left atrial appendage LAA management, today announced that the company will be participating in the upcoming Canaccord 41st Annual Growth Conference. AtriCures management is scheduled to present on Wednesday, August 11, 2021, at 8:00 a.m. Eastern Time. Interested parties may access a live and archived audio webcast of the presentation by visiting the Inv 